Logo image of BHST

BIOHARVEST SCIENCES INC (BHST) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BHST - CA09076J2074 - Common Stock

5.33 USD
-0.28 (-4.91%)
Last: 12/26/2025, 8:00:02 PM
Fundamental Rating

2

Taking everything into account, BHST scores 2 out of 10 in our fundamental rating. BHST was compared to 36 industry peers in the Personal Care Products industry. BHST may be in some trouble as it scores bad on both profitability and health. BHST is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BHST had negative earnings in the past year.
BHST had a negative operating cash flow in the past year.
BHST had negative earnings in each of the past 5 years.
In the past 5 years BHST always reported negative operating cash flow.
BHST Yearly Net Income VS EBIT VS OCF VS FCFBHST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

BHST has a Return On Assets of -66.58%. This is amonst the worse of the industry: BHST underperforms 94.44% of its industry peers.
BHST's Return On Equity of -415.37% is on the low side compared to the rest of the industry. BHST is outperformed by 86.11% of its industry peers.
Industry RankSector Rank
ROA -66.58%
ROE -415.37%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BHST Yearly ROA, ROE, ROICBHST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 200 -200

1.3 Margins

The Gross Margin of BHST (54.00%) is worse than 63.89% of its industry peers.
BHST's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BHST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.45%
GM growth 5YN/A
BHST Yearly Profit, Operating, Gross MarginsBHST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

0

2. Health

2.1 Basic Checks

BHST does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for BHST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BHST Yearly Shares OutstandingBHST Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 100M 200M 300M 400M
BHST Yearly Total Debt VS Total AssetsBHST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2M 4M 6M 8M 10M

2.2 Solvency

BHST has an Altman-Z score of -2.16. This is a bad value and indicates that BHST is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.16, BHST is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
A Debt/Equity ratio of 2.58 is on the high side and indicates that BHST has dependencies on debt financing.
BHST has a Debt to Equity ratio of 2.58. This is amonst the worse of the industry: BHST underperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.58
Debt/FCF N/A
Altman-Z -2.16
ROIC/WACCN/A
WACC7.82%
BHST Yearly LT Debt VS Equity VS FCFBHST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 -5M -10M

2.3 Liquidity

A Current Ratio of 0.80 indicates that BHST may have some problems paying its short term obligations.
The Current ratio of BHST (0.80) is worse than 86.11% of its industry peers.
BHST has a Quick Ratio of 0.80. This is a bad value and indicates that BHST is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.48, BHST is doing worse than 86.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.48
BHST Yearly Current Assets VS Current LiabilitesBHST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 1M 2M 3M 4M 5M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for BHST have decreased strongly by -734.76% in the last year.
BHST shows a strong growth in Revenue. In the last year, the Revenue has grown by 111.68%.
BHST shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 217.48% yearly.
EPS 1Y (TTM)-734.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.51%
Revenue 1Y (TTM)111.68%
Revenue growth 3Y217.48%
Revenue growth 5YN/A
Sales Q2Q%101.88%

3.2 Future

The Earnings Per Share is expected to grow by 31.77% on average over the next years. This is a very strong growth
Based on estimates for the next years, BHST will show a very strong growth in Revenue. The Revenue will grow by 88.58% on average per year.
EPS Next Y-4%
EPS Next 2Y31.18%
EPS Next 3Y31.77%
EPS Next 5YN/A
Revenue Next Year161.11%
Revenue Next 2Y107.4%
Revenue Next 3Y88.58%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BHST Yearly Revenue VS EstimatesBHST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
BHST Yearly EPS VS EstimatesBHST Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BHST. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BHST. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHST Price Earnings VS Forward Price EarningsBHST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BHST Per share dataBHST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

BHST's earnings are expected to grow with 31.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.18%
EPS Next 3Y31.77%

More info and screens

0

5. Dividend

5.1 Amount

BHST does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

BIOHARVEST SCIENCES INC

NASDAQ:BHST (12/26/2025, 8:00:02 PM)

5.33

-0.28 (-4.91%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-13 2025-11-13
Earnings (Next)03-30 2026-03-30
Inst Owners1.28%
Inst Owner ChangeN/A
Ins Owners15.27%
Ins Owner ChangeN/A
Market Cap107.56M
Revenue(TTM)22.43M
Net Income(TTM)-17.19M
Analysts82.5
Price TargetN/A
Short Float %0.45%
Short Ratio0.71
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.3%
Min EPS beat(2)-43.84%
Max EPS beat(2)60.44%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.18%
Min Revenue beat(2)-29.7%
Max Revenue beat(2)-0.66%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.8
P/FCF N/A
P/OCF N/A
P/B 25.99
P/tB 25.99
EV/EBITDA N/A
EPS(TTM)-1.19
EYN/A
EPS(NY)-0.26
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS1.11
BVpS0.21
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -66.58%
ROE -415.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.45%
GM growth 5YN/A
F-Score4
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 2.58
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 242.72%
Cap/Sales 12.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.48
Altman-Z -2.16
F-Score4
WACC7.82%
ROIC/WACCN/A
Cap/Depr(3y)257.83%
Cap/Depr(5y)N/A
Cap/Sales(3y)37.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-734.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.51%
EPS Next Y-4%
EPS Next 2Y31.18%
EPS Next 3Y31.77%
EPS Next 5YN/A
Revenue 1Y (TTM)111.68%
Revenue growth 3Y217.48%
Revenue growth 5YN/A
Sales Q2Q%101.88%
Revenue Next Year161.11%
Revenue Next 2Y107.4%
Revenue Next 3Y88.58%
Revenue Next 5YN/A
EBIT growth 1Y21.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.8%
EBIT Next 3Y58.05%
EBIT Next 5YN/A
FCF growth 1Y3.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.22%
OCF growth 3YN/A
OCF growth 5YN/A

BIOHARVEST SCIENCES INC / BHST FAQ

Can you provide the ChartMill fundamental rating for BIOHARVEST SCIENCES INC?

ChartMill assigns a fundamental rating of 2 / 10 to BHST.


What is the valuation status for BHST stock?

ChartMill assigns a valuation rating of 1 / 10 to BIOHARVEST SCIENCES INC (BHST). This can be considered as Overvalued.


Can you provide the profitability details for BIOHARVEST SCIENCES INC?

BIOHARVEST SCIENCES INC (BHST) has a profitability rating of 1 / 10.